- Home
- CNSP vs LCFY Comparison
CNSP vs LCFY Comparison
Compare CNSP & LCFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CNSP | LCFY |
|---|---|---|
| Founded | 2017 | 2009 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5M | 8.3M |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CNSP | LCFY |
|---|---|---|
| Price | $5.22 | $2.33 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $20.00 | N/A |
| AVG Volume (30 Days) | ★ 5.7K | 4.1K |
| Earning Date | 05-15-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8.03 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.90 | $2.10 |
| 52 Week High | $10.59 | $7.75 |
Technical Indicators
Market Signals| Indicator | CNSP | LCFY |
|---|---|---|
| Relative Strength Index (RSI) | 42.31 | 44.21 |
| Support Level | $5.15 | $2.28 |
| Resistance Level | $5.53 | $2.65 |
| Average True Range (ATR) | 0.17 | 0.12 |
| MACD | -0.10 | 0.00 |
| Stochastic Oscillator | 17.56 | 36.47 |
Price Performance
Historical ComparisonAbout CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.
About LCFY Locafy Limited
Locafy Ltd is an Australian company currently focused on commercializing its Software as a Service (SaaS) online marketing technology (Technology), which prominently delivers a cost-effective location-based digital marketing solution for small businesses in the key markets of the USA, Australia and Canada. The company has two operating segments: Publishing and SEO Agency. The company derives the majority of its revenue from license subscription fees and advertising fees. Geographically, the maximum revenue is derived from North America.